Core Viewpoint - China National Nuclear Corporation (CNNC) has signed a procurement agreement with Brazil's National Nuclear Energy Commission (CNEN) for the purchase of cobalt-60 irradiation sources, marking the first export of domestically produced cobalt-60 to the Latin American market and the first substantial outcome under the memorandum of understanding signed in October 2025 [1] Group 1 - The procurement agreement will enable CNEN to enhance the irradiation capabilities of its multi-functional irradiation facility at the Brazilian Nuclear and Energy Research Institute (IPEN) [1] - The cobalt-60 sources will be utilized in various fields including technology research, material studies, and irradiation processing, contributing to the advancement of irradiation technology for the benefit of Brazilian society [1]

Group 1 - The recent controversy surrounding Xibei's pre-made dishes has garnered significant public attention, with the company announcing plans to complete relevant adjustments by October 1, converting several dishes to be made fresh in-store [1] - The "Tender Grilled DHA Yellow Croaker" is still using frozen ingredients, as the restaurant lacks the necessary equipment to process the fish on-site [3] - A professional in the X-ray field confirmed that X-ray machines used for fish processing are safe, as they do not leave radiation residues on food and are commonly employed in food processing plants [3] Group 2 - The use of irradiation technology for food preservation, such as in popular items like spicy chicken feet and beef jerky, is noted to not affect the nutritional content of the food [3]

Core Viewpoint - The company utilizes cobalt-60 and electron accelerator irradiation technologies to provide sterilization services for healthcare products, food, pharmaceuticals, daily necessities, and packaging materials, along with modification services for polymer materials [1] Group 1 - The company offers comprehensive sterilization technology solutions to its clients [1] - Currently, the company has not conducted any research related to the chikungunya virus [1] - Generally, appropriate irradiation doses can effectively eliminate or inactivate microorganisms, including viruses [1]

Financial Performance - In 2024, the company achieved a revenue of 358.51 million yuan, representing a year-on-year growth of 3.99% [3] - The total profit amounted to 129.74 million yuan, with a year-on-year increase of 1.24% [3] - The net profit attributable to shareholders was 108.87 million yuan, reflecting a growth of 0.73% compared to the previous year [3] Strategic Development - The company aims to strengthen its traditional market competitiveness and implement integrated industrial development while gradually diversifying its business [2] - Future growth will be driven by favorable policy environments, increasing market demand, and ongoing optimization of investment layouts [4] Industry Outlook - The nuclear technology application industry is experiencing rapid expansion, with a growing market for irradiation services in healthcare, pharmaceuticals, and food sectors [4] - The company is positioned to benefit from the increasing demand for high-quality living standards, which will drive the need for irradiation sterilization services [4] Management and Communication - The company emphasizes the importance of shareholder communication and actively responds to investor inquiries [3] - Management has integrated market value management into performance assessment metrics, indicating a commitment to maintaining shareholder confidence [3]